PubMed HealthSearch

PubMed · 8389254

Benzidine glucuronidation in dog liver.

Abstract

Dog is an animal model for assessing aromatic amine-induced bladder cancer, and hepatic N-glucuronidation is proposed as an important pathway leading to initiation of carcinogenesis. Therefore, benzidine N-glucuronidation was evaluated with dog liver microsomes and slices. Microsomal benzidine UDP-glucuronosyltransferase activity was increased with a variety of detergents. For kinetic analysis, native microsomal preparations were separated into treated (detergent treated, not centrifuged) or soluble (detergent treated, centrifuged) fractions. The detergents Triton X-100, Lubrol PX, Emulgen 911 and CHAPS increased the specific activity of treated fractions relative to the native microsomes 3- to 6-fold. The specific activities of the soluble fractions were highest with Emulgen 911 and CHAPS at a detergent-to-protein ratio of 1. Subsequent studies used Emulgen 911 or CHAPS. Similar results were observed with either preparation. For treated preparations, the Km and Vmax values were 0.142 +/- 0.006 mM and 0.65 +/- 0.1 nmol/mg protein/min respectively. A variety of chemicals were tested for their effect on benzidine N-glucuronide formation. At 0.1 mM, the only effective inhibitors (< 50% of control) were 2-aminofluorene, estriol, 17-epiestriol, 2-OH-estrone, and 4-OH-estrone. With Emulgen-treated microsomes, the Ki values for 2-aminofluorene, 4-aminobiphenyl and estriol were 0.114 +/- 0.014, 0.347 +/- 0.032 and 0.047 +/- 0.003 mM respectively. 2-Aminofluorene and estriol were non-competitive inhibitors, while 4-aminobiphenyl was a competitive inhibitor. Slices incubated with these chemicals exhibited an inhibition profile similar to that observed with microsomes. Thus, N-glucuronidation of benzidine may be an important metabolic pathway in dog. Inhibition of benzidine N-glucuronidation by estriol and catechol estrones may be important in vivo events in aromatic amine-induced carcinogenesis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S R Babu, V J Wongsurawat, T V Zenser, B B Davis. 1993. Benzidine glucuronidation in dog liver.. https://doi.org/10.1093/carcin%2F14.5.893

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effects of n-tritriacontane-16,18-dione, curcumin, chlorphyllin, dihydroguaiaretic acid, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model.

The modifying effects of the naturally occurring antioxidants n-tritriacontane-16,18-dione (TTAD), curcumin, dihydroguaiaretic acid (DHGA), chlorophyllin, tannic acid and phytic acid on the initiation stage in a rat multi-organ carcinogenesis model were examined in male F344 rats. Animals were initiated with two i.p. injections of 2,2'-dihydroxy-di-n-propylnitrosamine (DHPN), followed by two i.g. administrations of N-ethyl-N-hydroxyethylnitrosamine (EHEN), and then three s.c. injections of 3,2'-methyl-4-aminobiphenyl (DMAB) during the first 3 weeks. Starting 1 day before the first carcinogen application, groups of rats received diet containing one of the antioxidants (0.2% TTAD, the others at 1% each) until 1 week after the last carcinogen exposure. Surviving animals were killed and complete autopsies were performed at the end of week 36. Histological examination revealed no inhibitory effects in terms of the multiplicities and/or incidences of neoplastic lesions in any of the organs examined, other than a significant increase in seminal vesicle atypical hyperplasia observed in rats treated with tannic acid. Thus, the antioxidants, with the exception of tannic acid, did not show any modifying effects on the initiation stage in the present multi-organ carcinogenesis model and at the present dose levels applied.

Aminobiphenyl Compounds

Decrease of prostaglandin E2 and 5-bromo-2'-deoxyuridine labeling but not prostate tumor development by indomethacin treatment of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate.

The modifying effects of indomethacin (IM) on rat prostate carcinogenesis induced by 3,2'-dimethyl-4-aminobiphenyl (DMAB) were investigated. F344 rats were given 50 mg/kg body weight of DMAB at 2-week intervals for 20 weeks and then received IM at a dose of 20 ppm in the drinking water for 37 weeks. Separate groups additionally received testosterone propionate (TP) in Silastic tubes throughout the experiment. DMAB alone induced carcinomas in situ in the ventral lobe and in combination with TP caused invasive carcinomas of the dorso-lateral and anterior lobes and seminal vesicles. No clear suppression by IM of development of in situ carcinomas or invasive carcinomas was observed. In a short-term satellite experiment, it was revealed that prostaglandin E2 (PGE2) levels in the dorso-lateral prostate and seminal vesicles, but not the ventral prostate, were significantly reduced by IM and that TP itself also suppressed PGE2 levels. The 5-bromo-2'-deoxyuridine labeling index in the ventral prostate was significantly decreased by IM administration. These results indicate that while IM can efficiently suppress tissue PGE2 levels, it does not inhibit tumor development in the prostate or seminal vesicles of rats in the present model.

Aminobiphenyl Compounds

Co-oxidative metabolism of 4-aminobiphenyl by lipoxygenase from soybean and human term placenta.

]4-aminobiphenyl (4-ABP) co-oxidation catalyzed by the human term placental lipoxygenase (HTPLO), purified by affinity chromatography, was studied in the presence of linoleic acid (LA). Soybean lipoxygenase (SLO) which is extensively employed as a model lipoxygenase, was used for comparison. Spectral analyses of reaction media containing 4-ABP, LA, and SLO/HTPLO suggested the disappearance of substrate (deltaA at 270 nm) and a gradual appearance of a new peak at 315 nm, indicating a metabolite formation. Under optimal assay conditions, SLO exhibited a specific activity of 350 nmoles of 4-ABP depleted/min/nmole of enzyme. To observe the maximal rate of co-oxidation by the HTPLO (45 nmoles of 4-ABP depleted/min/mg protein), an incubation of 50 microM 4-ABP, 2 mM LA, and 80 microg/ml protein at pH 7.4 was essential. 4-ABP was also oxidized by SLO in the presence of H2O2, although at a lower rate. The reversed-phase HPLC analysis of organic extracts of the incubations of 4-ABP with SLO and H2O2/LA as well as HTPLO and LA showed the formation of a major peak which was identified by GC-MS as 4,4'-azobis(biphenyl). The addition of GSH, BHT, and BHA to the enzymatic incubations decreased the formation of 4-ABP metabolite, suggesting the generation of a free radical as the initial metabolite during 4-ABP oxidation. Both the SLO and HTPLO mediated reactions were significantly inhibited by nordihydroguaiaretic acid, gossypol, and 5,8,11-eicosatriynoic acid. Collectively, these results suggest that the co-oxidation catalyzed by HTPLO may be the underlying biochemical mechanism responsible for the transplacental toxicity of 4-ABP.

Aminobiphenyl Compounds